Transcend Wealth Collective, LLC

SEC CIK: 0001776082
Latest filing: Aug 4, 2026

SEC filings (opens in a new tab)

NVS holding history

Novartis AG in every 13F filed by Transcend Wealth Collective, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVS overview All 13F holders of NVS Full Q2 2026 holdings

Shares (Q2 2026): 8,348
Value: $1.31M
% of portfolio: 0.1%
Quarters held: 21; Since Q1 2021

Holdings of NVS by Transcend Wealth Collective, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	8,348	$1.31M	0.1%	−745−8.2%	Reduced	Holders
Q1 2026	9,093	$1.39M	0.1%	−134−1.5%	Reduced	Holders
Q4 2025	9,227	$1.27M	0.1%	−436−4.5%	Reduced	Holders
Q3 2025	9,663	$1.24M	0.1%	−490−4.8%	Reduced	Holders
Q2 2025	10,153	$1.23M	0.1%	−249−2.4%	Reduced	Holders
Q1 2025	10,402	$1.16M	0.1%	+14+0.1%	Added	Holders
Q4 2024	10,388	$1.01M	0.1%	−45−0.4%	Reduced	Holders
Q3 2024	10,433	$1.20M	0.1%	−740−6.6%	Reduced	Holders
Q2 2024	11,173	$1.19M	0.1%	−47−0.4%	Reduced	Holders
Q1 2024	11,220	$1.09M	0.1%	−100−0.9%	Reduced	Holders
Q4 2023	11,320	$1.14M	0.1%	−192−1.7%	Reduced	Holders
Q3 2023	11,512	$1.17M	0.1%	−573−4.7%	Reduced	Holders
Q2 2023	12,085	$1.22M	0.1%	+169+1.4%	Added	Holders
Q1 2023	11,916	$1.10M	0.1%	−466−3.8%	Reduced	Holders
Q4 2022	12,382	$1.12M	0.1%	−237−1.9%	Reduced	Holders
Q3 2022	12,619	$959.0K	0.1%	−146−1.1%	Reduced	Holders
Q2 2022	12,765	$1.08M	0.1%	−942−6.9%	Reduced	Holders
Q1 2022	13,707	$1.20M	0.1%	+409+3.1%	Added	Holders
Q4 2021	13,298	$1.16M	0.1%	+1,426+12.0%	Added	Holders
Q3 2021	11,872	$1.01M	0.1%	+11,872	New	Holders
Q2 2021	0	$0	0.0%	−12,003−100.0%	Sold out	Holders
Q1 2021	12,003	$1.02M	0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.